trial

Atypical Antipsychotic Treatment Effect On Brain Function In Schizophrenia Measured By FMRI

NCTId NCT01234454
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 34 (actual)
Sponsored by University of North Carolina, Chapel Hill
Primary completion 2005-06
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
34 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2002-01
Primary completion
2005-06
Eligibility
ALL · 18 Years · 60 Years

Interventions & indications

Drugs
RisperidoneOlanzapine

Sponsors

University of North Carolina, Chapel HillLead Sponsor

Investigators

1
AYSENIL BELGERPrincipal Investigator

Sites

1 total
Chapel Hill, United States

Facts & assertions

4 sourced
Enrollment
34
Phase
NA
Primary Completion Date
2005-06
Status
COMPLETED
relationships
The graph out of here
drug
Risperidone
drug
Olanzapine
drug
lead_sponsor
University of North Carolina, Chapel Hill
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
AYSENIL BELGER
person